N 1922, Dandy 5 performed the first third ventriculocisternostomy by a subfrontal, translamina terminalis approach. One year later, Mixter 13 used a urological endoscope to puncture the floor of the third ventricle. During the last 10 to 15 years, ETVC has become popular for the treatment of patients with obstructive hydrocephalus from various origins. 3, 6, [9] [10] [11] 15 The procedure relies on the ability of the subarachnoid spaces to absorb CSF adequately and on favorable anatomy at the level of the brainstem, floor of the third ventricle, and prepontine cistern. Patients with expansive tumors in the posterior fossa, particularly intrinsic brainstem tumors, are often not thought to be candidates for an ETVC if the brainstem is pushed anteriorly against the clivus. When that is the case, the area for fenestration--between the clivus and the BA--is smaller and the procedure poses a greater risk (Fig. 1 ).
14 Thus, many of these patients have undergone placement of a VP shunt. In patients with DPGs, obstructive hydrocephalus develops in the terminal stages of their illness, and its associated symptoms have generally been treated either with steroid and analgesic agents or by the placement of a shunt. 2 Often, this surgery is performed late in the course of the illness, and the patient requires hospitalization of several days, which for some families is undesirable. We therefore elected to perform ETVCs in patients with DPGs or other lesions in the brainstem region in an attempt to provide palliation and possibly decrease the hospital stay and steroid medication requirements.
Clinical Material and Methods
We retrospectively reviewed the charts of all patients who had brainstem tumors, excluding tectal gliomas, who underwent an ETVC at our institution. In all cases there were one or more features of symptomatic hydrocephalus (headaches, new-onset nausea and vomiting, decreased level of consciousness, and mental status changes), and all had undergone MR imaging or both MR imaging and computed tomography of the head preoperatively to determine if the ventricle size and anatomy would allow for an ETVC. Data were evaluated in accordance with hospital policies and the Health Insurance Portability and Accountability Act regulations but were deemed exempt from institutional review board approval. rigid endoscope. After cannulation of the lateral ventricle, the 0˚ working endoscope was placed in the lateral ventricle and through the Monro foramen into the third ventricle. After inspection of the floor of the third ventricle, an opening in the floor was made with a small biopsy forceps. The jaws of the forceps were kept closed for the initial breech but were then opened to enlarge the hole. A No. 3 French Fogarty catheter was required in three cases to enlarge the opening further. The endoscope was then placed through the opening into the prepontine cistern, and that space was examined for the presence of arachnoid adhesions. In the patient in whom the procedure was performed using the flexible endoscope, the same procedure was performed using the biopsy forceps designed for the flexible ventriculoscope. Intraventricular catheters were not left in the patients.
Postoperative follow-up examination was performed in all patients and consisted of clinical evaluation by history, physical examination, and postoperative MR imaging at 6 weeks or sooner, depending on the patient's clinical course. Long-term follow up consisted of clinical assessments and imaging studies (either MR imaging or computed tomography) as dictated by clinical concerns. At 6 weeks to 3 months after the ETVC, cine MR images were obtained in all patients.
Results

Patient Population
Thirteen patients underwent an ETVC between November 1998 and December 2004. The clinical details of this cohort are provided in Table 1 . Nine patients harbored DPGs, two had ependymomas (one with a recurrent ependymoma around the brainstem and the other with metastatic disease in the third ventricle), one harbored a residual cervicomedullary astrocytoma (fibrillary astrocytoma Grade II), and one had a primitive neuroectodermal tumor. The mean age of the four boys and nine girls at the time of surgery was 5.8 years (range 1-15 years).
Presenting Signs and Symptoms
The patients presented with clinical features reflective of increased ICP or hydrocephalus (for example, headaches, nausea/vomiting, and lethargy), long-tract symptoms (that is, ataxia or hemiparesis), or cranial nerve palsies. All patients were symptomatic before surgery and had presented with new or worsening symptoms. The main preoperative clinical feature was headache, which was occasionally associated with vomiting, in 11 patients. These headaches were either a new symptom or were intensified despite analgesic treatment or increasing doses of steroid agents. A decreased level of consciousness was present in three patients. Preoperative imaging studies were obtained in all patients; hydrocephalus (new increase in the size of the lateral ventricles) was documented on all imaging studies, and periventricular edema was noted in eight cases. The presence of edema on the imaging studies and patient symptomatology were not associated.
Adjuvant Therapy
All patients but one underwent either radiotherapy or chemotherapy (Table 1) , including thalidomide in four of the patients harboring DPGs. Cytoreductive surgery had been performed in three patients (two with ependymomas and one with the recurrent cervicomedullary low-grade astrocytoma) before they underwent ETVC.
Postoperative Course
The patients were transferred to the recovery room and then the general neurosurgical floor and were discharged home within a median of 2 days (range 1-8 days, mean 2.75 days). One patient presented with an atypical brainstem lesion and a biopsy sample of the lesion had been obtained via a retrosigmoid craniotomy. Five days later, she was somnolent and underwent an ETVC. She was discharged home 2 days later. Two patients died in the hospital shortly after the ETVC, of acute respiratory deterioration due to aspiration. The postoperative recovery in the remaining patients was uneventful.
Operative Details
In nine cases, no significant increase in the intraventricular pressure was noted on insertion of the trocar in the lateral ventricle. In all but one of these nine patients, the floor of the third ventricle was thin; in four patients (three with a DPG and one with an ependymoma) preoperative imaging had demonstrated periventricular edema. The pressure was significantly increased in four patients (three with a DPG and one with a cervicomedullary tumor), with CSF exiting under pressure through the opening in the trocar.
The ventriculocisternostomy was made using the forceps in all cases; this was followed by dilation of the hole with a balloon in three cases. The scope was advanced through the opening into the prepontine cistern in the remaining 10 cases. A ventriculocisternostomy was deemed to be of sufficient size if there was evidence of turbulent flow of CSF in the third ventricle, and the BA trunk and cerebral peduncles could be visualized in the prepontine cistern in the absence of arachnoidal membranes. This was accomplished in all patients with no operative complications, and none of the patients suffered any worsening of their preexisting neurological deficits. External ventricular drains were not left in situ. 
Surgical Outcomes
All patients had improvements of their headaches or regained a normal level of consciousness in the immediate postoperative period. Other symptoms, such as cranial nerve palsies and long-tract signs, were either stable or improved. All patients with headaches had good long-term control of the symptom except one. This patient was a 13-year-old girl who underwent an ETVC for headache 6 months after a DPG was diagnosed. The procedure provided immediate and excellent resolution of her pain. Ten months later, her headaches returned; she could not be weaned off her steroid agents and significant steroid-related toxicity began to develop. Magnetic resonance imaging demonstrated no increase in ventricle size, but dissemination was evident. Therefore, the decision was made to place a shunt.
Postoperative imaging was performed in 11 patients. The ventricle size was decreased in eight of these patients and remained unchanged in three. Survival was calculated in months from the date of the procedure to the date of death. One patient with a DPG was lost to follow up. One patient was still alive at the time this paper was composed, and the date used to calculate her survival time was November 1, 2005. Thus, the mean survival of the cohort was 9.4 months; for those patients with a DPG, it was 2.7 months.
Discussion
Endoscopic third ventriculocisternostomy has become the method of choice for treatment of obstructive hydrocephalus. It is an effective method of managing the obstruction but has known complications. Unlike VP shunt therapy, however, which has known long-term complications, such as infection and recurring ventricular catheter obstruction, 7 ETVC does not appear to accrue complications. 17 Nevertheless, technical considerations associated with this procedure have made it risky in inexperienced hands, with tragic consequences on occasion. 4, 16, 18 Some of the contraindications of this procedure are expansion of the brainstem such that the prepontine cistern is either obliterated or occupied by a mass, displacement of the BA, or an abnormal floor of the third ventricle. 14 We have described nine patients who harbored DPGs and four with tumors of various origins in the area around the brainstem, whose hydrocephalus was treated with ETVC. There were no operative complications. All patients except for two were discharged from the hospital within a median of 2 days. The patients all experienced immediate resolution of the symptoms that had prompted the need for surgery, and in only one patient was symptom control not considered good beyond the early postoperative period. All but one patient with DPG ultimately died of their illnesses. The treatment of patients with tumors in this region of the brain is difficult, and the development of hydrocephalus is often a terminal event. Many physicians would opt to treat patients at this stage of their disease with supportive measures alone. We believed that symptomatic relief could provide these patients good palliation, and this procedure was performed with that goal in mind. In all cases this goal was accomplished, and although objective measurement of this procedure's ICP success is impossible, all caretakers, as well as the parents of the patients, believed that there was benefit.
Several interesting observations were noted in the review of these cases. Although all patients were symptomatic, increases in intracranial/intraventricular pressure were generally not documented. There were only four patients with significantly increased pressure: one with the cervicomedullary junction tumor and three with a DPG. This may suggest that, to some extent, the pathophysiology in patients with DPG was related to absorptive difficulties and that obstruction at the level of the aqueduct may not have been the sole cause of the hydrocephalus. All patients experienced symptomatic relief after the procedure, however, indicating that it certainly played a role.
All patients had classic symptoms of increased ICP, and some had associated worsening of their neurological deficits. In addition, hydrocephalus was noted to have developed in all patients, and preexisting ventriculomegaly was present in only one patient in whom there was further significant increase in third ventricle size. Furthermore, thin- ning of the floor of the third ventricle was present in all but one patient, suggesting that although ICP was not increased according to the measures used, there was evidence of increased ICP by other criteria. Although evidence of distortion of the brainstem or displacement of the BA was present, no technical difficulties were encountered in any of the surgeries. The BA was not seen through the floor of the third ventricle in the majority of patients, although pulsations indicating its position were clearly seen anterior to the mammillary bodies. The BA had an oblique/horizontal course in the patient with recurrent ependymoma and was noted to be in the midline of the floor of the third ventricle, coursing from the mammillary bodies to the hypophysial recess. In this patient, a site away from the artery and somewhat lateral to the visualized midline was chosen for the perforation. No side effects could be attributed to the placement of the hole laterally in this patient, who experienced excellent relief of symptoms.
At the time of this review, all but one patient had died of their disease. Only one patient required placement of a VP shunt, none of the patients had closure of the ETVC, and all had excellent relief of symptoms of obstructive hydrocephalus in their remaining time.
The terminal treatment of patients with DPGs is often compounded by the development of obstructive hydrocephalus. The incidence varies from approximately 15 to 60%, and most patients undergo placement of a VP shunt. 1, 2, 12 Many of these patients were or had been taking high doses of steroid drugs for symptomatic relief of symptoms of increased ICP and worsening baseline neurological deficits. The relatively high doses of steroid agents required to manage these symptoms carry significant side effects, many of which are unacceptable to the patients and their families, who are looking for good quality of life at this particular stage of the illness. In contrast, ETVC appeared to be an appealing procedure that would provide benefits, treat the symptoms, and possibly reduce the high doses of steroids required. Amano, et al., 1 successfully treated three patients with DPG with an ETVC. In this larger series, we have demonstrated that ETVC can accomplish most of the stated goals. It is difficult to clarify in this group of patients whether the procedure resulted in any significant change in the dose of steroid medication because many of the patients were already receiving very high doses and we did not attempt to wean them off the drug at this point in their clinical course.
Conclusions
We believe that ETVC can be performed in patients with DPG or with anatomy thought to be unfavorable for it. It provided symptomatic relief in all of our patients and did not have any associated complications. We suggest that this procedure is useful in the treatment of patients with these very difficult tumors, but we caution that experience with neuroendoscopy may be crucial to avoiding possible significant complications.
